The aim of the present study was to identify the sites of the inhibitory action of TNF␣ (tumor necrosis factor alpha) on LH/hCGstimulated testosterone formation. By using cultured porcine Leydig cells as a model, TNF␣ was shown to inhibit testosterone secretion when testicular cells were stimulated with hCG but not when incubated with 22R-hydroxycholesterol (a cholesterol substrate derivative that readily passes through cell and mitochondrial membranes). Such an observation suggested that the cytokine may affect cholesterol transport and/or availability to cytochrome P450scc in the mitochondria. Specifically, we report here that TNF␣ reduced in a dose-and time-dependent manner hCG-induced StAR (steroidogenic acute regulatory protein) levels. The maximal and half-maximal effects were obtained with 20 ng/ml (1.2 nM) and 1.6 ng/ml (0.09 nM) of TNF␣, respectively. Maximal inhibitory effects of TNF␣ on StAR messenger RNA and protein levels were obtained after 48 h of treatment. Additionally, the presence of TNF␣ receptors P55 in terms of protein (identified through cross-linking experiments) and messenger RNA (identified through RT-PCR analysis) suggested that the effects of the cytokine are directly exerted on the testicular steroidogenic cell type.
time-dependent manner hCG-induced StAR (steroidogenic acute regulatory protein) levels. The maximal and half-maximal effects were obtained with 20 ng/ml (1.2 nM) and 1.6 ng/ml (0.09 nM) of TNF␣, respectively. Maximal inhibitory effects of TNF␣ on StAR messenger RNA and protein levels were obtained after 48 h of treatment. Additionally, the presence of TNF␣ receptors P55 in terms of protein (identified through cross-linking experiments) and messenger RNA (identified through RT-PCR analysis) suggested that the effects of the cytokine are directly exerted on the testicular steroidogenic cell type. (Endocrinology 139: [2863] [2864] [2865] [2866] [2867] [2868] 1998) I N THE PAST few years, a framework of data has suggested an inhibitory action for tumor necrosis factor -␣ (TNF␣) in male gonadal function, particularly in Leydig cell steroidogenesis. The TNF␣ that affected Leydig cells could originate from interstitial macrophages (1) and/or from the circulatory system (2) . Interstitial macrophages might be activated during an immune challenge or chronic inflammatory diseases, resulting in production of elevated levels of TNF␣ in the vicinity of the Leydig cells (3) . Elevated TNF␣ levels in the circulatory system have been observed in patients with critical illness, burns, and sepsis (3) (4) (5) . It is of interest to note that those patients have depressed gonadal function (6, 7) . Additionally, more direct observations indicate that TNF␣ is probably involved in the decrease in male gonadal activity: 1) a severe hypogonadism was observed in male rats injected ip (8) or iv (9) with endotoxin, a substance known to stimulate TNF␣ production; 2) recombinant human TNF␣ (2-4 ϫ 10 5 U/kg⅐24 h) administration by continuous infusion to male Wistar rats induced a dramatic decline in testosterone concentration and severe seminiferous epithelium damage (2) . The increase in LH and FSH levels in these TNF␣ treated male rats would indicate that the detrimental effects of the cytokine are primarily exerted on the testis; 3) by using an in vitro model (i.e. cultured purified Leydig cells) we have shown that TNF␣ exerted a profound inhibitory effect on LH/hCG stimulated-testosterone formation (10) .
Together, although these data strongly suggested that TNF␣ is an inhibitor of testosterone formation under gonadotropin control, the sites of action of the cytokine and the expression of TNF␣ receptors supporting a direct interaction between the cytokine and the testicular cell type still remain to be identified in Leydig cells. The steroidogenesis process involves at least two mechanisms: 1) transport of cholesterol substrate in the inner mitochondrial membrane, a process that involves probably several mediators and particularly StAR (steroidogenic acute regulatory protein) (11); 2) transformation of cholesterol into testosterone which results from different steroidogenic enzyme activities (12) .
By using cultured porcine Leydig cells, as an experimental model, we report here that TNF␣ exerts its inhibitory action on Leydig cell steroidogenesis mainly through a decrease in StAR expression and that such an inhibitory action is probably mediated by TNF␣ receptor p55 expressed in the testicular cells.
Materials and Methods Materials
Human CG (hCG CR 121 13450 IU/mg) was a gift of Dr R. E. Canfield (Rockford, IL). DME-Ham's F-12 medium, M-MLV and TRIzol were obtained from Life Technologies (Eragny, France). Collagenase/dispase was obtained from Boehringer (Mannheim, Germany), human recom- 
Leydig cell preparation and culture
Leydig cells were prepared from immature porcine testes (2-3 weeks old) by collagenase treatment (13) . Briefly, decapsulated testes were minced and washed in DME/Ham's F-12 medium (1:1). After collagenase dissociation (0.5 mg/ml, 90 min at 32 C), cells were washed by centrifugation (200 ϫ g for 10 min). The pellet was then resuspended and submitted to two successive sedimentations of 5 and 15 min. The crude interstitial cells were recovered from the supernatants, and Leydig cells were prepared from this fraction by Percoll gradient centrifugation. The purity of Leydig cells was more than 90%, as determined by histochemical 3␤-hydroxysteroid dehydrogenase staining. Leydig cells were plated in Falcon (Los Angeles, CA) 24-multiwell plates (0.5 ϫ 10 6 cells/ dish) and cultured at 32 C in a humidified atmosphere of 5% CO 2 , 95% air in DME/Ham's F-12 medium (1:1) containing sodium bicarbonate (1.2 mg/ml), 15 mm 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES), and gentamicin (20 g/ml). This medium was supplemented with insulin (2 g/ml), transferrin (5 g/ml), and ␣-tocopherol (10 g/ml).
Testosterone measurement
Testosterone levels were measured in the culture medium by using a previously reported specific RIA (14) .
Western blot analysis
StAR protein contents in whole Leydig cells and in isolated mitochondria were identified through Western blot analysis. For isolation of mitochondria, the harvested cells were pelleted by centrifugation at 200 ϫ g for 10 min. The pelleted cells were resuspended in ice-cold buffer A consisting of 275 mm sucrose, 10 mm Tris-HCl, pH 7.4, 1 mm EDTA (0.5 ml of buffer/75 ϫ 10 6 cells), and homogenized with a Teflon homogenizer. Cellular fragments and nuclei were removed from homogenates by centrifugation at 960 ϫ g for 15 min. The pellet was resuspended in buffer A, homogenized, and centrifuged under the same conditions. The supernatants were pooled and centrifuged at 8,600 ϫ g for 15 min to yield the mitochondrial pellet. To purify mitochondria, the crude mitochondrial pellet was suspended in isolation buffer and centrifuged at 960 ϫ g for 3 min. The resultant supernatant was centrifuged twice at 8,600 ϫ g for 15 min.
Proteins from whole Leydig cells and isolated mitochondria were resolved on 12% SDS/polyacrylamide gels and electrophoretically transferred to nitrocellulose membranes using 25 mm Tris, 185 mm glycine, pH 8.3, containing 20% methanol. The transfer was performed at a constant voltage of 100 V for 45 min. Following transfer, the membrane was incubated in a blocking buffer (TBS buffer containing 10% nonfat dry milk) overnight at 4 C. The membrane was rinsed three times with TBS/Tween 0.1% (3 ϫ 10 min), then incubated with an antibody raised against a ten amino acid peptide (88 -98) of the 30 kDa StAR protein (1/1000 dilution in TBS containing 2% nonfat dry milk) for 1 h at room temperature. The membrane was rinsed with TBS/Tween 0.1% (3 ϫ 10 min) and then incubated with horseradish peroxidase-labeled goat antirabbit IgG (CovalAb, 1/1000 dilution in TBS containing 2% nonfat dry milk) for 1 h at room temperature. The membrane was thoroughly washed with TBS/Tween 0.1% (3 ϫ 10 min) and then with TBS. Bound antibodies were detected by chemiluminescence using a CovalAb detection kit and Biomax MR film from Kodak. Protein concentration was determined by the Bradford assay (15).
I-TNF␣ binding and affinity cross-linking experiments
TNF␣ was labeled with carrier-free Na 125 I by the Iodo-Gen method (16) and had a specific activity of 1700 Ci/mmol. For binding experiments, cultured Leydig cells were incubated at 4 C for 4 h with 125 I-TNF␣ in a total volume of 0.2 ml. At the end of the incubation, cells were washed three times with ice-cold PBS and incubated with disuccinimidyl suberate (2 mm). After 30 min at 4 C, the cells were washed with PBS and scraped off with scraping buffer (Tris 10 mm, pH 7, sucrose 0.25 m, EDTA 1 mm, PMSF 1 mm, leupeptin 10 g/ml). After centrifugation (300 ϫ g, 10 min) proteins were extracted with a triton buffer (Tris 10 mm pH 7, EDTA 0.1 mm, Triton X100 1%, PMSF 1 mm, leupeptin 50 g/ml) 40 min at 4 C. After a second centrifugation, proteins were analyzed by SDS-PAGE. Dried gels were exposed 15 days to Kodak film.
RNA extraction
Total RNAs were extracted from porcine Leydig cells with TRIzol reagent, a mono-phasic solution of phenol and guanidine isothiocyanate. This reagent is an improvement to the single-step RNA isolation developed by Chomczynski and Sacchi (17) . The amount of RNA was estimated by spectophotometry at 260 nm.
RT-PCR analysis
Single stranded complementary DNAs (cDNAs) were obtained from reverse transcription of 3 g of total RNAs using random hexanucleotides as primer (5 m), in the presence of dNTP (0.2 mm), dithiothreitol (10 m) and M-MLV (10 U/l), 1 h at 37 C. cDNA (1 l of RT mixture) were amplified by PCR with Taq polymerase (0.01 U/l), dNTP (50 m), and specific primers (2 m). The mixture was first heated at 92 C for 3 min and then 25 cycles of 92 C for 30 sec, 57 C for 30 sec, 70 C for 30 sec, then 70 C for 5 min. PCR products were analyzed on 2% agarose gel and visualized using a UV (254 nm) table (Appligène). Intensities bands were estimated by densitometric scanning using the BioImage scanner (BioImage, Cheshire, UK). The data were expressed as StAR/␤actin messenger RNAs (mRNAs) ratio. The oligonucleotides primers for StAR were: 5ЈTGGAGAGGCTTTATGAGGAGC3Ј (forward), 5ЈGCCAGGT-GAGTTTGGTCTTCG3Ј (reverse). StAR amplified products were 337 bp. The oligonucleotides primers for ␤actin were (18): 5ЈTTGCTGATCCA-CATCTGCTG3Ј (forward), 5ЈGACAGGATGCAGAAGGAGAT3Ј (reverse). ␤actin amplified products were 146 bp. The oligonucleotides primers for TNF␣ R55 were: 5ЈTGCTGCACCAAGTGCCACAAAG3Ј (forward), 5ЈCAGATGGTGTCCTGTTTCTTC3Ј (reverse). R55 amplified products were 326 bp. The oligonucleotides primers for TNF␣ R75 were: 5ЈCTCTTCCAGTTGGACTGATTG3Ј (forward), 5ЈTCTCCAGG-GAGCTGCTGCTG3Ј (reverse). R75 amplified products were 221 bp.
PCR analysis for StAR and ␤actin were carried out from the logarithmic phase of amplification. PCR amplified products were checked by restriction enzymes. RT-PCR primers were designed inside separate exons to avoid any bias due to residual genomic contamination. Moreover, for all primers, no amplification was observed when PCR was performed on RNA preparations. For the figures, scanned images were inverted.
Northern blot analysis
About 15 g of total RNA (denaturated 15 min at 65 C in the presence of formaldehyde 2.2 m, formamide 12.5 m, 1 ϫ 3(N-morpholino)propanesulfonic acid: MOPS) were electophoresed on 1.2% agarose/2.2 m formaldehyde gel. After migration in 0.02 m MOPS running buffer, RNAs were transferred to nitrocellulose membrane Hybond-C extra (Amersham, UK) in 10 ϫ SSC (1.5 m NaCl, 0.15 m sodium citrate) and fixed at 80 C for 2 h. cDNA probes (StAR, 1.6 kb NotI-SalI and GAPDH, 1.7 kb PstI) were labeled with 30 Ci of [␣ 32 P] dCTP (SA, 10 9 dpm/g DNA) using a random primed labeling kit (Promega, Madison, WI). Labeled probes were separated from free nucleotides by a G50 spin column. After 3 h of prehybridation at 42 C, filters were hybridized with labeled probe (1-4 ϫ 10 6 cpm/ml) overnight at 42 C in 50% formamide, 5 ϫ SSPE (0.9 m NaCl, 50 mm sodium phosphate, 5 mm EDTA, pH 7.4), 5 ϫ Denhardt's solution (1 g Ficoll, 1 g polyvinylpyrrolidone, 1 g BSA/ liter), 1% SDS and 100 g/ml herring sperm DNA. Afterward, membranes were washed four times in 2 ϫ SSC, 0.1% SDS (20 min, RT), followed by 40 min at 55 C. Filters were exposed to Kodak X-OMAT S films at Ϫ70 C for 1-2 days. Intensities of autoradiographic bands were estimated by densitometric scanning using the BioImage scanner (BioImage). The data were expressed as StAR/GAPDH mRNAs ratio.
Data analysis
All experimental data are presented as the mean Ϯ sd of triplicate determinations of three replicate cultures within each treatment group. All experiments reported here were repeated at least three times with independent cell preparations. A representative experiment of each series of experiments is presented. Statistical significance between groups was determined by Student's t test using the StatWorks (Hyden and Son Ltd, London, UK) package on a Macintosh computer. Differences are accepted as significant at P Ͻ 0.05.
Results

TNF␣ inhibited cholesterol mobilization
In cultured Leydig cells, TNF␣ (20 ng/ml, 72 h) had no effect on basal testosterone secretion (Fig. 1) . The cytokine inhibited (90% decrease, P Ͻ 0.001) testosterone production when Leydig cells were stimulated with LH/hCG (3 ng/ml, 3 h), but not when incubated with a cholesterol substrate derivative, which readily passes through cell and mitochondrial membranes (22R-hydroxycholesterol, 5 g/ml, 2 h) (Fig. 1) . These data suggest that the inhibitory action of TNF␣ resulted from an antagonistic interaction with the steroidogenic activity of LH/hCG. The disappearance of the inhibitory action of the cytokine in the presence of a cholesterol substrate derivative, which is readily diffusable to the inner mitochondrial membrane, without any active transport, suggests that TNF␣ may exert an inhibitory action on cholesterol transport. Together these observations make StAR a potential target for TNF␣ action in Leydig cells.
TNF␣ effects on StAR mRNA
TNF␣ inhibited in a dose-dependent manner StAR mRNA levels as shown through RT-PCR (Fig. 2) approach. The maximal inhibitory (P Ͻ 0.001) effect of the cytokine was observed with 20 ng/ml, 1.17 nm (Fig. 2) , and the IC 50 was obtained with 1.6 ng/ml (0.09 nm).
Such an inhibitory effect of the cytokine (20 ng/ml, 48 h) was also observed when StAR was identified through Northern blot analysis (mRNA size: 4.4 kb, 2.7 kb, Fig. 3 ).
As expected, hCG induced a rapid (2 h) significant (P Ͻ 0.001) enhancement of StAR mRNA levels (Fig. 4) . As depicted in Fig. 4 , TNF␣ had no effect on hCG-induced StAR expression between 0.5 and 6 h. However, long-term treatment with TNF␣ (20 ng/ml) resulted in a time-dependent decrease of StAR mRNA. The effect of the cytokine was detected at 24 h (P Ͻ 0.01) and was maximal at 48 h (P Ͻ 0.004) (Fig. 5) . Figure 6A gives a summary of immunoblot analysis of StAR protein accumulation in porcine Leydig cells treated with hCG, TNF␣, and their combination. As expected, StAR protein levels were markedly increased (at least 3-fold in the four experiments) in hCG-treated cells compared with untreated control cells. TNF␣ treatment of Leydig cells abolished the hCG-induced increase in StAR expression (the inhibition reaching at least 63% in the four experiments). TNF␣, after 48 h of treatment, inhibited hCG-induced StAR protein expression with a similar pattern in whole Leydig cells (Fig.  6B ) and isolated mitochondria (Fig. 6C) . Maximal inhibitory effects of TNF␣ on StAR protein were obtained after 48 h of treatment (data not shown).
TNF␣ effects on StAR protein
TNF␣ receptors
TNF␣ receptors were identified in terms of proteins and mRNAs. Cross-linking experiments showed a unique band of 72 kDa (Fig. 7A, lane 1) . This band was specific in that it disappeared in the presence of an excess (50 nm) of unlabeled TNF␣ (Fig. 7A, lane 2) . According to the observation of Hohmann et al. (19) , cross-linked products were generated by a single cross-linking reaction involving one (17 kDa) of the three TNF␣ molecules of the bound trimer and the receptor protein. This suggests, therefore, a molecular mass of about 55 kDa (for the 72 kDa cross-linked product in Fig. 7A ), which is related to the p55 form of the cytokine receptor. In these experiments, no other cross-linked product giving rise to a higher molecular mass receptor was detected even after a longer exposure (60 days).
The p55 receptor was also detected in terms of mRNA. Indeed, RT-PCR for p55 receptor demonstrates the presence of a single band in Leydig cells (Fig. 7B) . By using RT-PCR analysis, we were not able to detect transcripts for p75 receptor in this testicular cell type (Fig. 7B) .
Discussion
Although the conversion of cholesterol into pregnenolone has been considered as the rate limiting step of steroidogenesis for a long time, recent findings suggest that the rate limiting step is the delivery of the cholesterol substrate to P450scc. Cholesterol transport can be thought of as occurring in two separate processes. The first part of the process is the mobilization of cholesterol from cellular stores to the outer mitochondrial membrane, whereas the second part consists of the transfer of cholesterol from the outer to the inner mitochondrial membrane (for review, see Ref. 11) . Different mechanisms have been involved in the transport of cholesterol. For the mobilization of cholesterol from cellular stores to the mitochondrial outer membrane, cytoskeleton and particularly intermediate filaments (20) have been implicated, as well as SCP2 (Sterol Carrier Protein 2), a nonspecific lipid transfer protein (21) . While not completely understood, the mitochondrial step has received considerable enlightenment over the past few years. Three proteins seem to be at play: SAP (steroidogenesis activator peptide), a peptide isolated from mitochondria may play a role in cholesterol transfer (22) , PBR (peripheral benzodiazepine receptor), and VDAC (voltage dependent anion channel) may associate at particular areas of mitochondria, the contact sites, to favor cholesterol transfer (23) and StAR (steroidogenic acute regulatory protein), a mitochondrial protein that favors the translocation of cholesterol across the intermembrane space (24) . StAR seems to have a great importance in cholesterol transportation because this protein is under both acute (25) and chronic regulation by hCG, its expression is restricted to steroidogenic tissues and a nonsense mutation leads, in humans, to an absence of steroid production (congenital lipoid adrenal hyperplasia, 26) The aim of the present study was to clarify whether the anti-LH action of TNF␣ on testosterone formation was related to a regulatory action on StAR expression. Indeed, we (10) and others (27) (28) (29) , using Leydig cells from porcine (10), mouse (27, 28) , and rat (29) testis, have reported that TNF␣ inhibited LH/hCG-induced (10) or cAMP-induced (27, 28) testosterone production. Indeed, to inhibit LH-induced testosterone production, TNF␣ has been shown to involve different mechanisms such as redistribution of the cytoskeleton elements (our unpublished data), and steroidogenic enzymes (for example P450scc and P450c17 in mouse/rat Leydig cells, [27] [28] [29] . That an inhibitory action on cholesterol transport was probably also involved in TNF␣ action was suggested by the fact that incubation of Leydig cells with 22R-hydroxycholesterol (a cholesterol substrate derivative that readily passes through cell membranes) reversed most of the inhibitory effects of TNF␣. According to these observations, we have identified, in the present study, StAR as a target for TNF␣ action in Leydig cells. Indeed, TNF␣ decreased hCG-induced StAR mRNA and protein levels in Leydig cells. In previous experiments, we show that TNF␣ maximal inhibitory effect on hCG-induced testosterone production was obtained after 48 h of treatment (10) . TNF␣ inhibitory action on StAR levels (the present study) and on testosterone production (10) were kinetically similar (48 h), reinforcing the idea that the decrease in StAR expression is a crucial target of the cytokine during its inhibitory action on Leydig cell steroidogenesis. TNF␣ must be considered now as one of the major factors involved in the regulation of StAR expression, including also insulin-like growth factor I (30) and LPS (31) . Indeed, insulinlike growth factor I, a growth factor involved in maturation and differentiation of granulosa cells, increases steroidogenesis in those cells by enhancing, synergistically with FSH, StAR mRNA and protein expression (30) . As for endotoxin, ip injection of LPS to male mouse induces a rapid (within 2 h) and a prolonged (up to 9 days) decrease in serum testosterone level (31) . The early depression of serum testosterone seems to be associated with a decrease in StAR protein levels only while the prolonged decrease corresponds to a inhibition of P450c17 protein and mRNA levels in Leydig cells (31) . These discrepancies between action of LPS (31) and TNF␣ (our present study) on StAR expression are not known. However, it could be due to species specificity (mouse vs. pig) because in mouse Leydig cells TNF␣ inhibited LH-induced testosterone production by decreasing P450c17 expression (27) , whereas in porcine Leydig cells, TNF␣ decrease StAR protein and mRNA expression (the present study).
TNF␣ inhibitory action on StAR levels occurred at a concentration (0.09 nm) compatible with the K d range of the cytokine binding sites found on Leydig cells (10) . These observations suggest a direct action of TNF␣ on Leydig cells. Indeed, it is reported here that TNF␣ may use the p55 receptor (rather the p75 receptor) in porcine Leydig cells because protein and mRNA of this receptor type were found in this testicular cell type. P55 receptors have been implicated in many biological processes triggered by TNF␣ including cytokine production in fibroblasts (32) and anti-FSH action in Sertoli cells (33) . The p75 receptors have also been associated, at high abundance, with cell death (34) .
With regard to the mechanisms involved in the negative effect of TNF␣ on StAR mRNA levels, it might be due to a decrease in the transcriptional activity and/or mRNA stabilization. TNF␣ may affect StAR gene expression through interactions, with transcriptional factors that might bind to the StAR gene promoter (35, 36) . In this context, TNF␣ may antagonize the cAMP production and/or the cAMP action, i.e. induction of proteins that regulate StAR gene transcription such as SF-1 (steroidogenic factor-1), which has been shown to regulate, in human, StAR gene expression (36, 37) . Indeed, in the experimental model used here, we have previously shown that TNF␣ inhibited both cAMP formation induced by LH/hCG and cAMP action (through 8-bromocAMP, 10). As TNF␣ activates different intracellular signaling pathways (protein kinase C, sphingomyelinase, NFkB, 34), it remains to be determined which of these pathways (negatively) cross-talks with the cAMP pathway under the control of LH/hCG. In summary, by using a model of cultured porcine Leydig cells, we have shown that the inhibitory action of TNF␣ on LH/hCG-induced testosterone formation might be exerted
